Pediatric Infectious Disease

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  6 (2024)
Volume  5 (2023)
Volume  4 (2022)
Volume  3 (2021)
Volume  2 (2020)
Volume  1 (2019)
Related articles

VOLUME 2 , ISSUE 1 ( January-March, 2020 ) > List of Articles

REVIEW ARTICLE

Diagnosis and Management of Hepatitis B and Hepatitis C Infections in Children

Malathi Sathiyasekaran, Ganesh Ramaswamy

Citation Information : Sathiyasekaran M, Ramaswamy G. Diagnosis and Management of Hepatitis B and Hepatitis C Infections in Children. Pediatr Inf Dis 2020; 2 (1):12-18.

DOI: 10.5005/jp-journals-10081-1238

License: CC BY-NC 4.0

Published Online: 21-10-2020

Copyright Statement:  Copyright © 2020; The Author(s).


Abstract

The hepatitis B virus (HBV) and hepatitis C virus (HCV) in most children remain asymptomatic, but have the potential to progress to chronic hepatitis, cirrhosis, end-stage liver disease, and hepatocellular carcinoma. Vertical transmission is a unique feature seen with both these viruses and plays an important role in the natural history and management. Since prevention is better than cure, every effort should be made to prevent these diseases as significant transmission occurs during the perinatal period. Therefore, it is very essential that all pediatricians/gastroenterologists treating children with HBV and HCV infections be aware of the details relating to the viruses before considering therapy.

PDF Share
  1. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
  2. Batham A, Narula D, Toteja T, et al. Systematic review and meta-analysis of prevalence of hepatitis B in india. Indian Pediatr 2007;44(9):663–674.
  3. Petruzziello A, Marigliano S, Loquercio G, et al. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016;22(34):7824–7840. DOI: 10.3748/wjg.v22.i34.7824.
  4. Sievert W, Altraif I, Razavi HA. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011;31(Suppl 2):61–80. DOI: 10.1111/j.1478-3231.2011.02540.x.
  5. Squires JE, Balistreri WF. Hepatitis C virus infection in children and adolescents. Hepatol Commun 2017;1(2):87–98. DOI: 10.1002/hep4.1028.
  6. Sood A, Suryaprasad A, Trickey A, et al. The burden of hepatitis C virus infection in Punjab, india: a population-based serosurvey. PLoS One 2018;13(7):e0200461.
  7. Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002;67(1):20–26. DOI: 10.1002/jmv.2187.
  8. Chang MH. Natural history of hepatitis B infection in children. J Gastroenterol Hepatol 2000;15:E11–E19. DOI: 10.1046/j.1440-1746.2000.02096.x.
  9. Sokal EM, Paganelli M, Wirth S, et al. European society of pediatric gastroenterology, hepatology and nutrition. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the european society of pediatric gastroenterology, hepatology and nutrition. J Hepatol 2013;59(4):814–829. DOI: 10.1016/j.jhep.2013.05.016.
  10. Karnsakul W, Schwarz KB. Hepatitis B and C. Pediatr Clin North Am 2017;64(3):641–658. DOI: 10.1016/j.pcl.2017.01.007.
  11. Trifan A, Stanciu C. Checkmate to liver biopsy in chronic hepatitis C? World J Gastroenterol 2012;18(39):5514–5520. DOI: 10.3748/wjg.v18.i39.5514.
  12. Indolfi G, Thorne C, El Sayed MH, et al. The challenge of treating children with hepatitis C virus infection. J Pediatr Gastroenterol Nutr 2017;64(6):851–854. DOI: 10.1097/MPG.0000000000001589.
  13. Balistreri WF, Murray KF, Rosenthal P, et al. The safety and effectiveness of ledipasvir-sofosbuvir in adolescents 12–17 years old with hepatitis C virus genotype 1 infection. Hepatology 2017;66(2):371–378. DOI: 10.1002/hep.28995.
  14. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018;67(4):1560–1599. DOI: 10.1002/hep.29800.
  15. European Association for the Study of the Liver. EASL 2017 clinical Practice guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67(2):370–398. DOI: 10.1016/j.jhep.2017.03.021.
  16. Sarin SK, Kumar M, Lau GK, et al. Asian-pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10(1):1–98. DOI: 10.1007/s12072-015-9675-4.
  17. CHT Yang, Yoo ER, Ahmed A. The role of direct-acting antivirals in the treatment of children with chronic hepatitis C. J Clin Transl Hepatol 2017;5(1):59–66.
  18. Ghany MG, Morgan AA, SLD-IDSA Hepatitis C Guidance Panel. Hepatitis C guidance 2019 update american association for the study of liver diseases-infectious diseases society of America recommendations for testing, managing and treating hepatitis C virus infection. Hepatology 2020;71:686–721. DOI: 10.1002/hep.31060.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.